- POSITIVE
Annual Revenue Walpar Nutritions Mar-2026 Annual Revenue is Rs 65 Cr which is growth of 8.6% YoY.
- POSITIVE
Annual Net Profit Walpar Nutritions Mar-2026 Annual Net Profit is Rs 2 Cr which is growth of 16.1% YoY.
20.50-1.00(-4.65%)
2,000
NSE Volume
NSE 18 Nov, 2026 2:49 PM
Walpar Nutritions quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Walpar Nutritions competitor comparison and performance snapshot within industry
Walpar Nutritions annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
31.1% | 60.7% | 65.4 | 60.3 | 51.4 | 29 | 26.8 | 6.1 | 16.7 | 12.8 | 6.5 | ||
Operating Exp. Ann. | 30.8% | 62% | 62.4 | 57.3 | 49.6 | 27.9 | 25.7 | 5.6 | 15.5 | 12 | 6 | |
Operating Profit Ann. | 53.6% | 42.1% | 2.9 | 2.8 | 1.8 | 0.8 | 1.1 | 0.5 | 1.2 | 0.8 | 0.4 | |
OPM Ann. % | 17.8% | -10.1% | 4.43% | 4.72% | 3.42% | 2.71% | 4.00% | 7.53% | 7.23% | 6.25% | 6.35% | |
30.2% | 60.5% | 62.9 | 57.8 | 50 | 28.5 | 26.5 | 5.9 | 16.5 | 12.7 | 6.4 | ||
EBITDA Ann. | 39.7% | 43.1% | 3 | 2.9 | 1.9 | 1.1 | 1.1 | 0.5 | 1.2 | 0.8 | 0.4 | |
EBITDA Ann. margin % | 8.4% | -9.4% | 4.64% | 4.89% | 3.68% | 3.64% | 4.16% | 7.60% | 7.23% | 6.25% | 6.35% | |
Interest Ann. | -30.7% | -12.9% | 0.1 | 0.1 | 0.2 | 0.3 | 0.5 | 0.2 | 0.7 | 0.4 | 0.2 | |
Depr. | 10.1% | 32% | 0.4 | 0.4 | 0.2 | 0.3 | 0.3 | 0.1 | 0.3 | 0.3 | 0.2 | |
PBT Ann. | 71% | 65.7% | 2.5 | 2.4 | 1.5 | 0.5 | 0.4 | 0.2 | 0.2 | 0.1 | 0 | |
Tax Ann. | 44.2% | - | 0.6 | 0.7 | 0.4 | 0.2 | -0.1 | 0 | 0.1 | 0.1 | 0 | |
88.2% | 58.5% | 2 | 1.7 | 1.1 | 0.3 | 0.4 | 0.2 | 0.1 | 0.1 | |||
Net Profit Ann. | 88.2% | 58.5% | 2 | 1.7 | 1.1 | 0.3 | 0.4 | 0.2 | 0.1 | 0.1 | ||
NPM Ann. % | 43.3% | 3.9% | 3.00% | 2.81% | 2.16% | 1.02% | 1.56% | 2.48% | 0.72% | 0.53% | 0.05% | |
EPS Adj. latest Ann. | 91.3% | 60% | 2.1 | 1.8 | 1.2 | 0.3 | 0.5 | 0.2 | 0.1 | 0.1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
8.5%
2Y CAGR
12.8%
3Y CAGR
31.1%
5Y CAGR
60.7%
7Y CAGR
26.2%
Total Revenue Annual growth is lower than historical averages.
Net Profit Ann.
1Y CHG
17.6%
2Y CAGR
34.8%
3Y CAGR
88.2%
5Y CAGR
58.5%
7Y CAGR
53.4%
Net Profit Annual growth is lower than historical averages.
Operating Exp. Ann.
1Y CHG
8.9%
2Y CAGR
12.2%
3Y CAGR
30.8%
5Y CAGR
62%
7Y CAGR
26.6%
Operating Expenses Annual Cr growth is lower than historical averages.
Walpar Nutritions balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Walpar Nutritions Mar-2025 Total Shareholders Fund is Rs 17 Cr which is growth of 13.1% YoY.
- POSITIVE
Total Assets Walpar Nutritions Mar-2025 Total Assets is Rs 40 Cr which is growth of 29.1% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
14.6% | 28.8% | 17 | 15 | 13.3 | 11.3 | 11 | 4.8 | 1.9 | 1.1 | 0.8 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | - | - | |
- | - | 0 | 1 | 1.6 | 2.6 | 2.6 | 2.6 | 0.6 | ||||
34.1% | 22.5% | 22.9 | 15.9 | 10.2 | 9.5 | 10.7 | 8.3 | 8.6 | 5.5 | 2.5 | ||
Total Capital Plus Liabilities Ann. | 22.1% | 20.5% | 39.9 | 30.9 | 23.5 | 21.9 | 23.4 | 15.7 | 13.2 | 9.2 | 3.9 | |
48.1% | 18.8% | 2.6 | 2.3 | 1.5 | 0.8 | 0.9 | 1.1 | 1.1 | 0.9 | 0.9 | ||
21.8% | 38.8% | 10.3 | 7.1 | 6.4 | 5.7 | 6.5 | 2 | 1.3 | 0.9 | 0.9 | ||
22.3% | 16.7% | 29.6 | 23.9 | 17.1 | 16.2 | 16.9 | 13.7 | 11.9 | 8.2 | 3 | ||
Total Assets Ann. | 22.1% | 20.5% | 39.9 | 30.9 | 23.5 | 21.9 | 23.4 | 15.7 | 13.2 | 9.2 | 3.9 | |
Contingent Liabilities plus Commitments Ann. | - | - | - | |||||||||
Bonus Equity Share Capital Ann. | - | - | - | |||||||||
Non Current Investments Unquoted Book Value Ann. | - | - | - | 4.7 | 4.7 | 2.8 | 2.9 | 0.1 | ||||
Current Investments Unquoted Book Value Ann. | - | - | - |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
29.1%
2Y CAGR
30.3%
3Y CAGR
22.1%
5Y CAGR
20.5%
7Y CAGR
23.3%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
44%
2Y CAGR
49.8%
3Y CAGR
34.1%
5Y CAGR
22.5%
7Y CAGR
22.6%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
13.3%
2Y CAGR
13.1%
3Y CAGR
14.6%
5Y CAGR
28.8%
7Y CAGR
47.9%
Total ShareHolders Funds Annual growth is lower than historical averages.
Walpar Nutritions ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Walpar Nutritions Mar-2025 Book Value Per Share is 18 Rs which is growth of 13.1% YoY.
- POSITIVE
ROE Walpar Nutritions Mar-2025 ROE is 12% which is growth of 0.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | -10.1% | 4.8% | 18.1 | 16 | 28.4 | 24.9 | 24.3 | 14.3 | 10 | 10 | 10 | |
RoA Ann. % | 54.3% | 38.7% | 4.92% | 5.47% | 4.73% | 1.34% | 1.79% | 0.96% | 0.92% | 0.74% | 0.08% | |
ROE Ann. % | 64.5% | 29.6% | 11.57% | 11.27% | 8.33% | 2.60% | 3.78% | 3.16% | 6.32% | 6.34% | 0.42% | |
ROCE Ann. % | 33.1% | 27.1% | 15.34% | 16.85% | 12.63% | 6.50% | 6.59% | 4.62% | 20.02% | 15.14% | 14.98% | |
Total Debt to Total Equity Ann. | -30.7% | -38.1% | 0.1 | 0 | 0.3 | 0.4 | 1.1 | 2.5 | 3.4 | 1.8 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
2.7%
2Y CAGR
17.9%
3Y CAGR
64.5%
5Y CAGR
29.6%
7Y CAGR
9%
ROE Annual % is growing slower than historical averages.
RoA Ann. %
1Y CHG
-10.1%
2Y CAGR
2%
3Y CAGR
54.3%
5Y CAGR
38.7%
7Y CAGR
31.1%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
1Y CHG
-13.3%
2Y CAGR
-12.6%
3Y CAGR
-8.6%
5Y CAGR
-5.2%
7Y CAGR
-2%
Current Ratio Annual is falling faster than historical averages.
Walpar Nutritions cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Walpar Nutritions Mar-2026 Cash From Operating Activity is Rs 1 Cr which is growth of -57.6% YoY.
- NEGATIVE
Net Cash Flow Walpar Nutritions Mar-2026 Net Cash Flow is Rs -1 Cr which is growth of -161.4% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.9% | -3% | 1.2 | 2.7 | 3.1 | 1.1 | -0.3 | 1.4 | -0.8 | -1.3 | -0.1 | ||
Cash from Investing Act. Ann. | - | - | -3.6 | -1.2 | -0.9 | 0.5 | -4.6 | -0.7 | -0.7 | -0.3 | -0.5 | |
Cash from Financing Act. Ann. | - | - | 1.8 | -0.4 | -2.2 | -1.5 | 4.3 | -0.1 | 1.1 | 2.1 | 0.8 | |
- | - | -0.7 | 1.1 | 0.1 | 0 | -0.6 | 0.6 | -0.4 | 0.5 | 0.1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-55.6%
2Y CAGR
-37.8%
3Y CAGR
2.9%
5Y CAGR
-3%
Cash from Operating Activity Annual is falling faster than historical averages.
Cash from Financing Act. Ann.
7Y CAGR
-2.2%
Cash from Financing Annual Activity growth is higher than historical averages.
